Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balkau

Showing results (71-80 of 205) with videos related to

Pageof 21
Sort By:
Diabetes Care|October 27, 2001
From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000E Eschwège, M A Charles, D Simon, et al.
Diabetes & Metabolism|June 18, 2011
Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR studyM R Skilton, C Lange, O Lantieri, et al.
Diabetes Care|August 1, 1996
Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in QuebecJ M Ekoé, F Thomas, B Balkau, et al.
Diabetes & Metabolism|March 18, 2018
Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300U/mL vs glargine 100U/mL in T2DMR Roussel, R Ritzel, E Boëlle-Le Corfec, et al.
Diabetologia|July 1, 1997
Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in CameroonJ C Mbanya, J Ngogang, J N Salah, et al.
Diabetes & Metabolism|May 21, 1998
Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescentsB Balkau, J Tichet, E Caces, et al.
Diabetologia|January 1, 1992
Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjectsB Balkau, E Eschwège, A Fontbonne, et al.
Journal of Clinical Epidemiology|January 1, 1991
The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-upB Balkau, E Eschwège, P Ducimetière, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|October 12, 2002
[Study of the motivation of physicians participating in public health research]J Cogneau, R Warck, J Tichet, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective studyP Maison, B Balkau, D Simon, et al.
Pageof 21

Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Diabetes Care|October 27, 2001
From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000E Eschwège, M A Charles, D Simon, et al.
Diabetes & Metabolism|June 18, 2011
Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR studyM R Skilton, C Lange, O Lantieri, et al.
Diabetes Care|August 1, 1996
Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in QuebecJ M Ekoé, F Thomas, B Balkau, et al.
Diabetes & Metabolism|March 18, 2018
Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300U/mL vs glargine 100U/mL in T2DMR Roussel, R Ritzel, E Boëlle-Le Corfec, et al.
Diabetologia|July 1, 1997
Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in CameroonJ C Mbanya, J Ngogang, J N Salah, et al.
Diabetes & Metabolism|May 21, 1998
Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescentsB Balkau, J Tichet, E Caces, et al.
Diabetologia|January 1, 1992
Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjectsB Balkau, E Eschwège, A Fontbonne, et al.
Journal of Clinical Epidemiology|January 1, 1991
The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-upB Balkau, E Eschwège, P Ducimetière, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|October 12, 2002
[Study of the motivation of physicians participating in public health research]J Cogneau, R Warck, J Tichet, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective studyP Maison, B Balkau, D Simon, et al.
Pageof 21